Novel Blood Serum Assay Diagnoses Neurodegenerative Diseases
Researchers from Japan have developed a novel assay that can detect α-synuclein seeds in the blood, instead of using cerebrospinal fluid.
Read MorePosted by Melanie Hamilton-Basich | May 30, 2023 | Hematology & Serology |
Researchers from Japan have developed a novel assay that can detect α-synuclein seeds in the blood, instead of using cerebrospinal fluid.
Read MorePosted by Chris Wolski | May 17, 2023 | Disease States |
Researchers have developed a liquid biopsy technique that may reveal signs of Parkinson’s disease in urine samples.
Read MorePosted by Melanie Hamilton-Basich | May 9, 2023 | Anatomic Pathology |
CND Life Sciences’ Syn-One Test detected the pathological form of alpha-synuclein in the skin of over 95% of patients diagnosed with a synucleinopathy, a group of disorders that includes Parkinson’s disease.
Read MorePosted by Melanie Hamilton-Basich | May 5, 2023 | Research |
While the concept of diagnostic windows has been developed in cancer research, this study examines whether it is relevant for other diseases.
Read MorePosted by Andy Lundin | Apr 17, 2023 | Disease States |
Researchers developed a biological test for Parkinson’s that detects the disease in individuals before cardinal movement symptoms arise.
Read More